{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-005537","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2024-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.361783+00:00","generated_at":"2026-05-31T06:16:14.648091+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"BioNexus Gene Lab reduces stockholder meeting quorum to one-third","bullets":["Board adopted amended bylaws on September 4, 2024, effective immediately.","Quorum for stockholder meetings lowered from majority to one-third of outstanding voting shares.","Amendment aligns with other governance provisions; no other bylaw changes disclosed.","Amended and Restated Bylaws filed as Exhibit 3.1 to the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-005537","json":"https://secwatch.observer/filing/0001477932-24-005537.json","markdown":"https://secwatch.observer/filing/0001477932-24-005537.md","text":"https://secwatch.observer/filing/0001477932-24-005537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793224005537/0001477932-24-005537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793224005537/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:16:14.648091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}